
CDSCO Guideline for Action on Spurious & NSQ Drugs
Amidst the heightened surveillance and enforcement actions initiated by different state licensing authorities (state FDAs) in India on Drugs and
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Please subscribe for latest posts and news with your email address.
Popular: Warning Letters, Recalls

Amidst the heightened surveillance and enforcement actions initiated by different state licensing authorities (state FDAs) in India on Drugs and

The USFDA has released a new draft guidance, Container Closure Systems for Human Drugs and Biological Products, outlining principles for

The USFDA has placed Dabur’s Dadra and Nager Haveli facility under Import Alert 66-40 in June 2026. This action follows

Qvents provides useful tools for QMS processes – Risk Assessments, Continuous Process Validations, Supply Chain Traceability Mapping of Drug Products. The Apps

The USFDA recently issued a warning letter to Intas Pharmaceuticals Limited (Dehradun facility, FEI 3005890633 in March 30, 2026), citing

The USFDA has issued a draft guidance for Establishing Impurity Specifications for Antibiotics in April 2026. This guidance is applicable
Please subscribe for latest posts and news with your email address.
Please subscribe for latest posts and news with your email address.
Be informed about current concerns and focus areas of regulators and auditors; Share your views, comments, hear from industry peers….
List your Job Openings with Qvents; Search for profiles matching the jobs requirements; View profiles, Connect with candidates.
Popular: Warning Letters, Recalls
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Dr.Reddys Laboratories
Dr.Reddys Laboratories
Be informed about current concerns and focus areas of regulators and auditors; Share your views, comments, hear from industry peers….
List your Job Openings with Qvents; Search for profiles matching the jobs requirements; View profiles, Connect with candidates.
Popular: Warning Letters, Recalls
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Dr.Reddys Laboratories
Dr.Reddys Laboratories

Amidst the heightened surveillance and enforcement actions initiated by different state licensing authorities (state FDAs) in India on Drugs and

The USFDA has released a new draft guidance, Container Closure Systems for Human Drugs and Biological Products, outlining principles for

The USFDA has placed Dabur’s Dadra and Nager Haveli facility under Import Alert 66-40 in June 2026. This action follows

Qvents provides useful tools for QMS processes – Risk Assessments, Continuous Process Validations, Supply Chain Traceability Mapping of Drug Products. The Apps

The USFDA recently issued a warning letter to Intas Pharmaceuticals Limited (Dehradun facility, FEI 3005890633 in March 30, 2026), citing

The USFDA has issued a draft guidance for Establishing Impurity Specifications for Antibiotics in April 2026. This guidance is applicable
Popular: Warning Letters, Recalls